Morie A. Gertz
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments 412
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research 150
- Nephrology top 0.02%
- Parathyroid Disorders and Treatments 93
- Oncology top 0.05%
- Cancer Treatment and Pharmacology 106
- Peptidase Inhibition and Analysis 96
- Molecular Biology top 0.02%
- Amyloidosis: Diagnosis, Treatment, Outcomes 444
- Protein Degradation and Inhibitors 118
-
- Neuroendocrine Tumor Research Advances 94
- Co-authors
- Angela DispenzieriRobert A. KyleMartha Q. LacyS. Vincent RajkumarPhilip R. GreippShaji KumarJohn A. LustSuzanne R. Hayman
- Cited by
- HematologyGeneticsNephrology
- Partner nations
- United StatesItalyIsrael
In The Last Decade
Morie A. Gertz
910 papers receiving 43.0k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Hematology 20.6k
- Genetics 9.9k
- Nephrology 6.4k
- Oncology 13.6k
- Molecular Biology 30.3k
Countries citing papers authored by Morie A. Gertz
This map shows the geographic impact of Morie A. Gertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morie A. Gertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morie A. Gertz more than expected).
Fields of papers citing papers by Morie A. Gertz
This network shows the impact of papers produced by Morie A. Gertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morie A. Gertz. The network helps show where Morie A. Gertz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Morie A. Gertz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 6 | |
| 5 | 2018 | 12 | |
| 6 | 2016 | 106 | |
| 7 | 2016 | 147 | |
| 8 | 2015 | 22 | |
| 9 | Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus. | 2014 | 0 |
| 10 | 2013 | 120 | |
| 11 | 2010 | 102 | |
| 12 | 2010 | 121 | |
| 13 | 2010 | 3 | |
| 14 | 2009 | 226 | |
| 15 | 2007 | 285 | |
| 16 | 2007 | 195 | |
| 17 | 2007 | 185 | |
| 18 | 2000 | 25 | |
| 19 | 1999 | 52 | |
| 20 | 1999 | 69 |
About Morie A. Gertz
Morie A. Gertz is a scholar working on Hematology, Genetics and Nephrology, having authored 945 papers that have together received 44.0k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (444 papers), Multiple Myeloma Research and Treatments (412 papers), Chronic Lymphocytic Leukemia Research (150 papers), Protein Degradation and Inhibitors (118 papers), Cancer Treatment and Pharmacology (106 papers), Peptidase Inhibition and Analysis (96 papers), Neuroendocrine Tumor Research Advances (94 papers) and Parathyroid Disorders and Treatments (93 papers). The work is most often cited by research in Hematology (20.6k citations), Genetics (9.9k citations) and Nephrology (6.4k citations). Morie A. Gertz has collaborated with scholars based in United States, Italy and Israel. Frequent co-authors include Angela Dispenzieri, Robert A. Kyle, Martha Q. Lacy, S. Vincent Rajkumar, Philip R. Greipp, Shaji Kumar, John A. Lust, Suzanne R. Hayman, Francis K. Buadi and Rafaël Fonseca. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.